Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AC Immune (ACIU) Profit After Tax: 2015-2025

Historic Profit After Tax for AC Immune (ACIU) over the last 10 years, with Sep 2025 value amounting to -$19.8 million.

  • AC Immune's Profit After Tax fell 412.11% to -$19.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$94.5 million, marking a year-over-year decrease of 198.11%. This contributed to the annual value of -$58.1 million for FY2024, which is 4.94% up from last year.
  • As of Q3 2025, AC Immune's Profit After Tax stood at -$19.8 million, which was up 27.94% from -$27.5 million recorded in Q2 2025.
  • AC Immune's Profit After Tax's 5-year high stood at $10.0 million during Q4 2023, with a 5-year trough of -$27.6 million in Q2 2024.
  • Over the past 3 years, AC Immune's median Profit After Tax value was -$19.8 million (recorded in 2025), while the average stood at -$16.5 million.
  • Its Profit After Tax has fluctuated over the past 5 years, first spiked by 151.36% in 2023, then slumped by 412.11% in 2025.
  • AC Immune's Profit After Tax (Quarterly) stood at -$23.1 million in 2021, then grew by 15.65% to -$19.5 million in 2022, then surged by 151.36% to $10.0 million in 2023, then plummeted by 359.91% to -$26.0 million in 2024, then crashed by 412.11% to -$19.8 million in 2025.
  • Its Profit After Tax stands at -$19.8 million for Q3 2025, versus -$27.5 million for Q2 2025 and -$21.2 million for Q1 2025.